Advertisement

ImmunoGen, Day One Surge On Cancer Drug Updates, But Arcus Dips

ImmunoGen, Day One Surge On Cancer Drug Updates, But Arcus Dips

ImmunoGen and Day One unveiled promising cancer treatment updates over the weekend, leading IMGN stock and DAWN stock to soar Monday.